PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 16597193-7 2006 Prednisone administration results in a decrease in ACTH secretion by the anterior pituitary, suppressing synthesis of glucocorticoids, DHEA, and DHEA metabolites. Prednisone 0-10 proopiomelanocortin Homo sapiens 51-55 8026943-5 1994 ME (0.49 +/- 0.10 pmol/mL) and NMECP (35.1 +/- 2.4 pmol/mg protein) levels after prednisone treatment were significantly higher (P < 0.05) than in basal conditions (0.29 +/- 0.08 pmol/mL and 27.14 +/- 2.4 pmol/mg protein), while no differences were found in catecholamine levels. Prednisone 81-91 proopiomelanocortin Homo sapiens 0-2 8232843-8 1993 Further, prednisone-induced increases in theta activity were significantly correlated with prednisone-induced decreases in CSF levels of somatostatin-like immunoreactivity, and prednisone-induced decreases in peak alpha activity were significantly correlated with decreases in CSF levels of norepinephrine and with relative increases (or lesser decreases) in CSF levels of beta-endorphin and beta-lipotropic hormone. Prednisone 9-19 proopiomelanocortin Homo sapiens 373-387 7515507-10 1994 Prednisone administration was also associated with significant decreases in plasma levels of adrenocorticotropic hormone (ACTH), cortisol, and 3-methoxy,4-hydroxyphenyl glycol (MHPG) and in cerebrospinal fluid (CSF) levels of ACTH, beta-endorphin (BE), beta-lipotropin (BLPH), somatostatin-like immunoreactivity (SLI), and norepinephrine (NE). Prednisone 0-10 proopiomelanocortin Homo sapiens 93-120 7515507-10 1994 Prednisone administration was also associated with significant decreases in plasma levels of adrenocorticotropic hormone (ACTH), cortisol, and 3-methoxy,4-hydroxyphenyl glycol (MHPG) and in cerebrospinal fluid (CSF) levels of ACTH, beta-endorphin (BE), beta-lipotropin (BLPH), somatostatin-like immunoreactivity (SLI), and norepinephrine (NE). Prednisone 0-10 proopiomelanocortin Homo sapiens 232-246 8232843-8 1993 Further, prednisone-induced increases in theta activity were significantly correlated with prednisone-induced decreases in CSF levels of somatostatin-like immunoreactivity, and prednisone-induced decreases in peak alpha activity were significantly correlated with decreases in CSF levels of norepinephrine and with relative increases (or lesser decreases) in CSF levels of beta-endorphin and beta-lipotropic hormone. Prednisone 91-101 proopiomelanocortin Homo sapiens 373-387 8232843-8 1993 Further, prednisone-induced increases in theta activity were significantly correlated with prednisone-induced decreases in CSF levels of somatostatin-like immunoreactivity, and prednisone-induced decreases in peak alpha activity were significantly correlated with decreases in CSF levels of norepinephrine and with relative increases (or lesser decreases) in CSF levels of beta-endorphin and beta-lipotropic hormone. Prednisone 91-101 proopiomelanocortin Homo sapiens 373-387 1977371-4 1990 Prednisone administration was associated with decreases in cerebrospinal fluid levels of corticotropin, norepinephrine, beta-endorphin, beta-lipotropin, and somatostatinlike immunoreactivity. Prednisone 0-10 proopiomelanocortin Homo sapiens 120-134 2709088-2 1989 The rationale for this treatment was that some patients might still have hormone-sensitive disease that was stimulated by weak androgens of adrenal origin, and that these androgens could be suppressed by prednisone through its negative feedback on secretion of adrenocorticotrophic hormone (ACTH). Prednisone 204-214 proopiomelanocortin Homo sapiens 291-295 2531180-7 1989 In the 3 groups the beta-endorphin decrease corresponded to the period of prednisone therapy; the increase was concomitant with the suspension of oral glucocorticoids. Prednisone 74-84 proopiomelanocortin Homo sapiens 20-34 13842204-0 1960 [Variations of adrenal reactivity to ACTH after arrest of a prolonged treatment by cortisone derivatives (deltacortisone) associated or not with depot ACTH or with testosterone]. Prednisone 106-120 proopiomelanocortin Homo sapiens 37-41 6090111-9 1984 In infants receiving prednisone and then prednisone plus ACTH, serum cortisol was suppressed to about one-quarter of baseline levels with the initiation of prednisone, and remained suppressed during ACTH administration. Prednisone 21-31 proopiomelanocortin Homo sapiens 199-203 6090111-9 1984 In infants receiving prednisone and then prednisone plus ACTH, serum cortisol was suppressed to about one-quarter of baseline levels with the initiation of prednisone, and remained suppressed during ACTH administration. Prednisone 41-51 proopiomelanocortin Homo sapiens 199-203 6327750-5 1984 A fourth such patient, however, treated with pharmacologic doses of prednisone, had a low normal ACTH response. Prednisone 68-78 proopiomelanocortin Homo sapiens 97-101 6286371-0 1982 Response of the adrenal to adrenocorticotropic hormone (ACTH) in hyperandrogenic women treated chronically with low doses of prednisone. Prednisone 125-135 proopiomelanocortin Homo sapiens 27-54 6286371-0 1982 Response of the adrenal to adrenocorticotropic hormone (ACTH) in hyperandrogenic women treated chronically with low doses of prednisone. Prednisone 125-135 proopiomelanocortin Homo sapiens 56-60 13800053-0 1960 Study of the adrenal response to ACTH after prolonged treatment with prednisone alone or in combination with ACTH or testosterone. Prednisone 69-79 proopiomelanocortin Homo sapiens 33-37 2889125-4 1987 Moreover, the magnitude of these reductions was inversely related to the magnitude of prednisone-induced reductions in plasma ACTH levels, suggesting a functional interaction between circulating corticosteroids, central somatostatin and pituitary ACTH release. Prednisone 86-96 proopiomelanocortin Homo sapiens 126-130 2889125-4 1987 Moreover, the magnitude of these reductions was inversely related to the magnitude of prednisone-induced reductions in plasma ACTH levels, suggesting a functional interaction between circulating corticosteroids, central somatostatin and pituitary ACTH release. Prednisone 86-96 proopiomelanocortin Homo sapiens 247-251 222143-4 1979 Five days after concluding the prednisone therapy, peak cortisol response to hypoglycemia had returned to near pretreatment levels although peak cortisol response in the adrenal gland to synthetic ACTH (22.3 +/- 1.1 microgram/dl) remained reduced (p less than 0.05). Prednisone 31-41 proopiomelanocortin Homo sapiens 197-201 4301373-0 1968 ACTH drip in prednisone resistant pemphigus. Prednisone 13-23 proopiomelanocortin Homo sapiens 0-4 14432517-0 1960 [The effect of prednisone on the 17-hydroxycorticosteroids in the plasma after ACTH- and pyrexal administration]. Prednisone 15-25 proopiomelanocortin Homo sapiens 79-83 13541154-0 1958 [Protein & lipoprotein electrophoretic picture of the serum in nephrotic syndrome of childhood, with special reference to changes observed in the course of treatment with ACTH & prednisone]. Prednisone 186-196 proopiomelanocortin Homo sapiens 175-179 13579959-0 1958 [Changes of blood transaminase in viral hepatitis in patients with pulmonary tuberculosis treated with prednisone & ACTH]. Prednisone 103-113 proopiomelanocortin Homo sapiens 120-124 13656630-0 1959 [Observations & remarks on hormone treatment with prednisone & ACTH in cases of pemphigus]. Prednisone 54-64 proopiomelanocortin Homo sapiens 71-75 13473128-0 1957 [Clinical observations on burns in children with special reference to ACTH & prednisone]. Prednisone 81-91 proopiomelanocortin Homo sapiens 70-74 13528599-0 1958 [Reaction of fractionated bilirubin in blood & of alkaline phosphatase in acute hepatitis treated with prednisone & ACTH]. Prednisone 107-117 proopiomelanocortin Homo sapiens 124-128 13532197-0 1958 [Prednisone-ACTH retard therapy in the prevention of adrenal atrophy during prednisone therapy]. Prednisone 1-11 proopiomelanocortin Homo sapiens 12-16 13532197-0 1958 [Prednisone-ACTH retard therapy in the prevention of adrenal atrophy during prednisone therapy]. Prednisone 76-86 proopiomelanocortin Homo sapiens 12-16 13453822-0 1957 [Changes in bone tissue during prolonged treatment with prednisone & ACTH; anatomo-clinical and experimental observations]. Prednisone 56-66 proopiomelanocortin Homo sapiens 73-77 13446442-0 1957 A COMPARISON of cortisone and prednisone in treatment of rheumatoid arthritis; a report by the Joint Committee of the Medical Research Council and Nuffield Foundation on Clinical Trials of Cortisone, ACTH and other therapeutic measures in chronic rheumatic diseases. Prednisone 30-40 proopiomelanocortin Homo sapiens 200-204 13384665-0 1956 [Considerations on the association of prednisone with ACTH in the treatment of rheumatoid arthritis]. Prednisone 38-48 proopiomelanocortin Homo sapiens 54-58 13242644-0 1955 The comparative effects of metacortandracin, 9-alpha-fluorohydrocortisone and hydrocortisone upon ACTH secretion in man. Prednisone 27-43 proopiomelanocortin Homo sapiens 98-102 20142368-10 2010 Receiver operating curve (ROC) analysis performed to predict a suppressed adrenal function on day 7 after the withdrawal of prednisone showed an area under the curve (AUC) of 0.76 (95% confidence interval (CI) 0.58-0.89) for cortisol after the administration of dexamethasone, which was in the range of the AUC of 0.78 (95% CI 0.6-0.9) for pre-intervention cortisol after the administration of ACTH. Prednisone 124-134 proopiomelanocortin Homo sapiens 394-398 31903560-0 2020 Prednisolone/prednisone as adrenocorticotropic hormone alternative for infantile spasms: a meta-analysis of randomized controlled trials. Prednisone 13-23 proopiomelanocortin Homo sapiens 27-54